International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Since Year 2012 | Open Access | Double Blind Reviewed

ISSN: 2319-7064

Downloads: 123

Research Paper | Pharmaceutical Science | India | Volume 9 Issue 2, February 2020


Anshupa Patel Gupta [2] | Himani Tambde [3]

Abstract: Ebola virus disease or simply Ebola is lethal viral hemorrhagic fever caused by Ebola viruses. Many outbreaks have been seen from 1976 to recent 2016, killing around 50 % of persons affected. The Ebola virus includes six species of virus out of which Zaire ebolavirus has highest mortality rate. To get protection against this virus, the vaccine was invented by scientists at the Public Health Agency of Canada (PHAC). In 2014, Merck got the licence to develop this from Newlink (which was first licensed from PHAC). Now Merck Sharp & Dohme Corp has got approval in December 2019 for manufacturing it under the trade name ERVEBO®. ERVEBO is a live recombinant viral vaccine in the form of sterile suspension for intramuscular injection. It is to be administered in single 1 ml dose. Though it has few adverse effects it will certainly be a milestone fighting against Ebola disease.

Keywords: Ebola virus, Ebola virus disease EVD, vaccine

Edition: Volume 9 Issue 2, February 2020,

Pages: 1858 - 1860

How to Cite this Article?

Anshupa Patel Gupta, Himani Tambde, "Ebola", International Journal of Science and Research (IJSR), Volume 9 Issue 2, February 2020, pp. 1858-1860,

How to Share this Article?

Enter Your Email Address

Click below to Watch Video Lecture of Above Article

Share this Video Lecture

Similar Articles with Keyword 'vaccine'

Downloads: 2

Review Papers, Pharmaceutical Science, Indonesia, Volume 11 Issue 3, March 2022

Pages: 76 - 77

PfSPZ Malaria Vaccine

Dwi Ayu Fani Novitasari

Share this Article

Downloads: 3 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Review Papers, Pharmaceutical Science, India, Volume 10 Issue 6, June 2021

Pages: 1431 - 1435

A Concise Review on Liposomes: A Novel Approach

Vivek Kumar Mishra [2] | Pallavi Tiwari [7]

Share this Article